ArticleCureus2025
A Case of a Heterozygous Female Patient With Ornithine Transcarbamylase (OTC) Deficiency Successfully Treated by Liver Transplantation in Adulthood.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ornithine transcarbamylase deficiency (OTCD) is a urea cycle disorder inherited in an X-linked manner. This report describes a case of a 27-year-old woman diagnosed with OTCD during childhood who experienced growth disturbances and an unstable clinical condition (nausea, vomiting, and hyperammonemia) despite strict dietary and pharmacological management, leading to a poor quality of life. She met the scoring criteria for liver transplantation (LT), received a living donor liver transplant (LDLT) from her mother, and is doing well post-transplant. LT is the only curative treatment available for OTCD, and recent technological advances have significantly improved outcomes in Japan. However, as female patients with OTCD were usually considered to have a mild phenotype, the induction and timing of LT are very difficult to decide. In addition, most LT in female patients with OTCD is performed in childhood; therefore, there are very few case reports of female OTCD patients with LT in adulthood. This case study provides guidance on the indications for LT in adult female OTCD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.